Table 1.
Clinically relevant mutations in neuroblastoma
Chr | Gene | Gene name | Status | Predisposition | Function | References |
---|---|---|---|---|---|---|
1p36.31 | CHD5 | Chromodomain helicase DNA binding protein | Deletion | Sporadical | Chromatin remodelling and gene transcription | [44] |
1p36.3–p36.2 | DFF45 | DNA fragmentation factor | Mutation | Sporadical | Apoptosis | [186] |
1q23.3 | DUSP12 | Dual specificity phosphatase 12 | SNP | Sporadical | Negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38) | [187] |
1p36.3 | UBE4B | Ubiquitination factor E4B | Mutation | Sporadical | Ubiquitination | [50] |
2p23 | ALK | Anaplastic lymphoma receptor tyrosine kinase | Mutation, amplification | Hereditable | Genesis and differentiation of the nervous system | [6, 7, 9, 188–197] |
2q35 | BARD1 | BRCA1-assosiated RING domain | SNPs | Sporadical | Interaction with the N-terminal region of BRCA1 | [87] |
4p12 | PHOX2B | Paired-like homeobox 2B | Germline missense or frameshift | Hereditable, sporadical | Transcription factor | [5, 83, 198–200] |
5q11.2 | DDX4 | DEAD box polypeptide 4 isoform | SNP | Alteration of RNA secondary structure | [187] | |
5q11.2 | IL31RA | Interleukin 31 receptor A precursor | SNP | Signaling via activation of STAT-3 and STAT-5 | [187] | |
6p22 | FLJ44180 | Long intergenic non-protein coding RNA 340 | SNP | – | [89] | |
6p22 | FLJ22536 | Long intergenic non-protein coding RNA 340 | SNP | – | [89] | |
9p21 | CKDNA | Cyclin-dependent kinase inhibitor 2A | Mutation, deletion | Sporadical | Cell cycle G1 control | [201–204] |
9p23–p24.3 | PTPRD | Protein tyrosine phosphatase, receptor type, D | Microdeletion | Signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation | [8, 9] | |
11q13 | CCND1 | Cyclin D1 | Amplification, rearrangement | Proto-oncogene, control of cell cycle/cellular proliferation | [56, 205] | |
11p11.2 | HSD17B12 | Hydroxysteroid (17-beta) dehydrogenase 12 | SNP | Converts estrone into estradiol in ovarian tissue | [187] | |
6q21 | LIN28B | Lin-28 homolog B | SNP | RNA binding protein, negatively regulates let-7 processing | [93] | |
11p15.4 | LMO1 | LIM domain only 1 | SNP, amplification | Sporadical | Cysteine-rich transcriptional regulator | [88] |
12q24 | PTPN11 | Protein tyrosine phosphatase, non- receptor type 11 | Mutation | Sporadical | Regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic | [206, 207] |
17q11.2 | NF1 | Neurofibromin 1 | Deletion | Negative regulator of the ras signal transduction pathway | [208] | |
17q13.1 | P53 | Tumor protein p53, TP53 | Mutation | Sporadical | DNA binding protein | [146] |
18q21.3 | DCC | Netrin 1 receptor | Mutation, deletion | Sporadical | Member of the immunoglobulin superfamily of cell adhesion molecules | [209] |
20p11 | SLC24A3 | Solute carrier family 24 | SNP | Sporadical | Plasma membrane sodium/calcium exchangers | [89] |